Iron infusion trial aims to boost energy in stomach cancer patients
NCT ID NCT05226169
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial is testing whether an iron infusion called ferric carboxymaltose can safely and effectively treat iron-deficiency anemia in people with advanced stomach cancer who are receiving palliative chemotherapy. The study plans to enroll 330 participants and will measure changes in hemoglobin levels over 12 weeks. If successful, this approach could improve quality of life and help patients better tolerate their cancer treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ferric carboxymaltose (iron infusion)
- What this could lead to
- If it works, this could provide a safe and effective way to treat iron-deficiency anemia in people with advanced gastric cancer, potentially improving their energy and ability to tolerate chemotherapy.
- What could go wrong
- This is a phase 3 trial, but it focuses on managing a side effect rather than treating the cancer itself. The benefit may be limited to certain patients, and iron infusions carry a small risk of allergic reactions or other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 138-736, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug combo targets Hard-to-Treat GI cancers
- New drug cocktail aims to tackle Hard-to-Treat stomach cancer
- New drug duo takes aim at hard-to-treat stomach cancer with liver metastases
- New stomach cancer surgery technique shows promise in early trial
- Tailored immunotherapy cocktail shows promise for tough stomach cancer
- New pill combo aims to fight stomach cancer when first treatment fails